title: Impact of the Cancer Risk Intake System on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy.
abstract: The Cancer Risk Intake System (CRIS), a computerized program that "matches" objective cancer risks to appropriate risk management recommendations, was designed to facilitate patient-clinician discussion. We evaluated CRIS in primary care settings via a single-group, self-report, pretest-posttest design. Participants completed baseline telephone surveys, used CRIS during clinic visits, and completed follow-up surveys 1 to 2 months postvisit. Compared with proportions reporting having had discussions at baseline, significantly greater proportions of participants reported having discussed tamoxifen, genetic counseling, and colonoscopy, as appropriate, after using CRIS. Most (79%) reported CRIS had "caused" their discussion. CRIS is an easily used, disseminable program that showed promising results in primary care settings.
authors.affiliation: Duke University Medical Center, Durham, NC 27710, USA. celette.skinner@duke.edu
authors.forename: Celette Sugg
authors.initials: CS
authors.lastname: Skinner
authors.forename: Susan M
authors.initials: SM
authors.lastname: Rawl
authors.forename: Barry K
authors.initials: BK
authors.lastname: Moser
authors.forename: Adam H
authors.initials: AH
authors.lastname: Buchanan
authors.forename: Linda L
authors.initials: LL
authors.lastname: Scott
authors.forename: Victoria L
authors.initials: VL
authors.lastname: Champion
authors.forename: Joellen M
authors.initials: JM
authors.lastname: Schildkraut
authors.forename: Giovanni
authors.initials: G
authors.lastname: Parmigiani
authors.forename: Shelly
authors.initials: S
authors.lastname: Clark
authors.forename: David F
authors.initials: DF
authors.lastname: Lobach
authors.forename: Lori A
authors.initials: LA
authors.lastname: Bastian
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000465:Algorithms; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000453:epidemiology* / Q000517:prevention & control; D003110:Colonic Neoplasms / Q000453:epidemiology* / Q000517:prevention & control; D003113:Colonoscopy; D003142:Communication; D003376:Counseling; D005260:Female; D005817:Genetic Counseling; D006801:Humans; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D010051:Ovarian Neoplasms / Q000453:epidemiology* / Q000517:prevention & control; D010342:Patient Acceptance of Health Care; D010353:Patient Education as Topic / Q000379:methods; D010817:Physician-Patient Relations; D011320:Primary Health Care; D018570:Risk Assessment / Q000379:methods*; D013629:Tamoxifen / Q000627:therapeutic use
chemical_list: D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen